tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Carlos Solorzano, 4 are a BUY (100%).
Analyst Carlos Solorzano, Previously, Carlos Solorzano worked at OPPENHEIMER.
Carlos Solorzano’s has documented 9 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ICPT, Intercept Pharmaceuticals at 01-Jun-2016.
Analyst best performing recommendations are on RLYP (RELYPSA).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Aug-2023
$19
$20
3 years 1 months 4 days ago
(27-Sep-2023)
2/8 (25%)
$0.42 (2.26%)
86
Buy Since 12-Jan-2022
$19
$15
3 years 1 months 4 days ago
(27-Sep-2023)
3/16 (18.75%)
$0.42 (2.26%)
57
Buy Since 03-Aug-2023
$19
$19
3 years 1 months 4 days ago
(27-Sep-2023)
11/14 (78.57%)
$0.42 (2.26%)
66
Hold Since 10-Nov-2020
$19
$13
3 years 1 months 4 days ago
(27-Sep-2023)
12/25 (48%)
$0.42 (2.26%)
39
Buy Since 10-Nov-2020
$19
$18
3 years 1 months 5 days ago
(26-Sep-2023)
6/27 (22.22%)
$0.29 (1.55%)
66
